Sugi Predict

Sugi Predict / Compounds / SCHEMBL1749121

SCHEMBL1749121

SCHEMBL1749121

COc1cc2c(-c3cc4c(C)ccnc4n3S(=O)(=O)c3ccc(C)cc3)cn(C)c2cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ PTGDR2 Q9Y5Y4 5/20 0.36
▸ PCSK9 Q8NBP7 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MET P08581 1/20 0.35
▸ AXL P30530 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ SCN9A Q15858 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ALDH3A1 P30838 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PDE4A P27815 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ PDE4C Q08493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1749150 0.91 IGF1R (0.39) IGF1RTP53PTGDR2PCSK9TSHR
SCHEMBL1748718 0.91 PTGDR2 (0.39) IGF1RTP53PTGDR2PCSK9TSHR
SCHEMBL27688034 0.90 IGF1R (0.40) IGF1RTP53PTGDR2PCSK9TSHR
SCHEMBL1748958 0.89 IGF1R (0.38) IGF1RTP53PTGDR2PCSK9TSHR
SCHEMBL5806641 0.88 IGF1R (0.37) IGF1RTP53PTGDR2PCSK9TSHR
SCHEMBL1748663 0.88 PTGDR2 (0.41) IGF1RTP53PTGDR2PCSK9MET
SCHEMBL1749798 0.88 PTGDR2 (0.39) IGF1RTP53PTGDR2PCSK9MET
SCHEMBL1749257 0.88 IGF1R (0.39) IGF1RTP53PTGDR2PCSK9TSHR
SCHEMBL1748824 0.88 IGF1R (0.39) IGF1RTP53PTGDR2PCSK9TSHR
SCHEMBL27687992 0.87 TP53 (0.39) IGF1RTP53PTGDR2PCSK9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968566-B2 Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors AVENTIS PHARMA S.A. (FR) 2011-06-28 — — US disclosed
US-20090233956-A1 NOVEL PYRROLO(2,3-b) PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2009-09-17 — — US disclosed
US-7528147-B2 Pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors AVENTIS PHARMA S.A. (FR) 2009-05-05 — — US disclosed
US-20070093480-A1 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors AVENTIS PHARMA S.A. (FR) 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233956-A1 NOVEL PYRROLO(2,3-b) PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS MAP3K19, MAP4K2, MAP3K1 IGF1R 817/4885TP53 966/4885PTGDR2 806/4885
US-20070093480-A1 Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors MAP3K19, MAP4K2, MAP3K1 IGF1R 817/4885TP53 966/4885PTGDR2 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.